Marrone Bio Innovations Stock

Marrone Bio Innovations EBIT per Employee

Delisted

The EBIT per Employee of Marrone Bio Innovations (MBII) as of Jul 25, 2026 is -103,027.59 USD. In the previous year, EBIT per Employee was 9,586.21 USD — a change of -1,174.75% (lower).

EBIT per Employee

-103,027.59USD

YoY

-1,174.75%

Last updated:

EBIT per Employee of Marrone Bio Innovations is 2026 -103,027.59 USD. EBIT per Employee of Marrone Bio Innovations was 2025 9,586.21 USD. It decreases by -1,174.75% lower compared to the previous year.
Access this data via the Eulerpool API

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

EBIT per Employee of Marrone Bio Innovations is -103,027.59 USD in 2026.

Access this data via the Eulerpool API

Workforce — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations